Neval yurttutan uyar

Dr. Neval yurttutan uyar


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
NUNeval yurttutan uyar
Neval yurttutan uyar
ASAhmed Kerem Sayar
Ahmed Kerem Sayar
AKAyşe Sesin Kocagöz
Ayşe Sesin Kocagöz
MSMuhittin Abdülkadir Serdar
Muhittin Abdülkadir Serdar
RZRehile Zengin
Rehile Zengin
MSMustafa Serteser
Mustafa Serteser
Introduction: We compared the diagnostic values of individual and composite biomarkers used in the prediction of bacteremia in adult emergency department patients. Methodology: First-hour blood levels of C- reactive protein, procalcitonin, interleukin-6, lactate, lipopolysaccharide-binding protein and white blood cell count were collected from a 30-person control group and 47 adult patients. Patients included in this study were admitted to the emergency department on suspicion of sepsis. We categorized patients according to presence/absence of sepsis and bacteremia. Our control group was categorized as S-B -, septic patients with bacteremia were S+B+, and septic patients without bacteremia were S+B-. Results: All biomarkers showed a statistically significant elevation when S+B- and S+B+ groups were compared with the S-B-. When S+B+ group was compared with the S+B- group only procalcitonin and lactate levels had statistically significant elevation (p < 0.005). Regression analysis demonstrated that lactate and procalcitonin were independently associated with having bacteremia in the state of sepsis and Hosmer-Lemeshow score was 0.772. The areas under the curve (AUC) values of biomarkers procalcitonin, lactate, C-reactive protein, combined 1 (procalcitonin+ lactate), and combined 2 (procalcitonin + lactate + C-reactive protein) were 0.773, 0.744, 0.523, 0.806, and 0.829 respectively. Conclusions: Combination of tests such as combined 1 or combined 2 were highly predictive of bacteremia in adult septic patients. Combined 2 demonstrated the best predictive performance and could be utilized as a tool to assist diagnosis of bacteremia before culture results are available.

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
RDRıdvan Dumlu
Rıdvan Dumlu
NUNeval yurttutan uyar
Neval yurttutan uyar
MAMeltem Ayaş
Meltem Ayaş
NANi̇lAy Aksoy
Ni̇lAy Aksoy
NÖNur Öztürk
Nur Öztürk
AKAyşe Sesi̇n Kocagöz
Ayşe Sesi̇n Kocagöz
Background/aim: Our study investigated the susceptibility rate of ceftazidime-avibactam and the risk factors associated with its resistance by analyzing gram-negative bacteria isolated from various patient samples. Materials and methods: Between March and November 2020, 1119 gram-negative bacteria strains were isolated from patient samples in Acıbadem Healthcare Group hospitals; ceftazidime-avibactam susceptibility results were evaluated using a 10/4µg (Oxoid, UK) disc and evaluated according to Eucast 2020 recommendations. Patient and isolate characteristics that could be risk factors were retrospectively investigated and statistically analyzed using SPSS 25.0. Results: Male patients made up 52% (n = 581) of the study's total patient population, and they averaged 55.5 ± 24.9 years old. Of 1119 gram-negative strains culture and antibiogram, 1023 (91.4%) were sensitive to ceftazidime-avibactam. An increased risk of resistance was observed with female gender (OR = 2.29; CI 95% [1.45-3.61]; p < 0.05), Pseudomonas aeruginosa (OR = 1.67, CI 95% [1.03-2.7]; p < 0.05), the presence of multidrug-resistance (MDR) (OR = 4.07, CI 95% [2.47-6.7]; p < 0.05) pandrug-resistance (PDR) (OR = 12, (CI) 95% [9.9-14.7] ]; p < 0.05) and admission to intensive care unit (ICU) (OR = 1.89, CI 95% [1.22-2.93]; p < 0.05). Conclusion: The resistance rate of ceftazidime-avibactam was found to be 8.6%, and it was thought that resistant strains produced metallo-ß-lactamase (MBL) type carbapenemase. Risk factors were female gender, Pseudomonas aeruginosa, MDR, PDR, and admission to ICU. Therefore, studying the ceftazidime-avibactam susceptibility test together with gram-negative bacteria identification, especially in groups at risk for resistance, is one of the important factors that can positively affect the success of treatment.

20 December 2023 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
YUYasemin Ucal
Yasemin Ucal
MSMuhittin Abdülkadir Serdar
Muhittin Abdülkadir Serdar
HKHande Karpuzoğlu
Hande Karpuzoğlu
NUNeval yurttutan uyar
Neval yurttutan uyar
MKMeltem Kilercik
Meltem Kilercik
AOAYSEL OZPINAR
AYSEL OZPINAR
Objectives: To evaluate the thyroid hormone levels and infection markers in COVID-19 patients and compare them to those in non-COVID-19 patients with infection in a large retrospective dataset. Methods: In this study, thyroid-stimulating hormone (TSH), thyroid hormones (free T3 and free T4), and several infection markers were reviewed. The study group was divided into three groups that had no thyroid-related disorders: control patients (Group 0; n=7,981), COVID-19 patients (Group 1; n=222), and non-COVID-19 patients with infection (Group 2; n=477). The data were assessed for correlation and group comparisons. Results: There was a reduction in median (25th–75th percentile) fT3 levels in COVID-19 patients 4.17 pmol/L (3.46–4.85) compared to non-COVID-19 patients with infection 4.65 pmol/L (4.12–5.15), p<0.0001. We detected a negative correlation between fT3 and neutrophil-to-lymphocyte ratio (NLR) in Group 1 (r=−0.534) and Group 2 (r=−0.346) (p<0.0001), indicating a relatively stronger link between fT3 and NLR in COVID-19 patients than non-COVID-19 patients with infection. Additionally, the fT3 levels remained significantly different between study groups when the model was adjusted for age, gender, and infection markers. Conclusions: COVID-19 and non-COVID-19 infections are associated with low fT3 levels, which likely represent the suppression of the hypothalamic-pituitary-thyroid axis from non-thyroidal illness syndrome.

19 September 2022 in Aktuelle Rheumatologie
Verified
Journal Article
Closed access
PDF file
NUNeval yurttutan uyar
Neval yurttutan uyar
Objective Anti-nuclear antibody (ANA) patterns are classified as nuclear, cytoplasmic or mitotic. The International Consensus on ANA patterns (ICAP) suggests three parameters for ANA reporting – assay type, results and advice for reflex testing – but has not yet reached a consensus on the reporting of cytoplasmic/mitotic patterns as ANA-negative or positive. We investigated the effect of ICAP’s two proposals for reporting cytoplasmic patterns as ANA-positive and negative with a view to the recommendation for reflex testing in a country that has no national reimbursement policies for automatic reflex testing. Methods This non-interventional descriptive study included 1241 patients with positive cytoplasmic ANA patterns. 442 patients were reported as ANA-negative and 799 as ANA-positive. Patients were followed up for a two-year period to determine testing recommendations based upon nuclear and cytoplasmic patterns. For statistical analysis, the t-test was used, with a significance threshold of p-value<0.05. Results Appropriate reflex orders were seen more commonly with cytoplasmic patterns reported as ANA-positive (27.30%) than with those reported as ANA-negative (5.51%, p-value<0.05). However, ANA-positive reports led to higher ordering of nuclear pattern reflex tests (12.97%) compared with ANA-negative reports (1.10%, p-value<0.05). A large group of patients (59.73% ANA-positive, 93.39% ANA-negative) did not receive reflex testing. Conclusion Reporting cytoplasmic patterns as ANA-positive was considered more significant, but reading the result report without considering the pattern and recommendation notes could lead to inappropriate reflex testing. Besides reaching a consensus for reporting cytoplasmic patterns as ANA-negative or positive, it is important to consider solutions to reimbursement policies for automatic reflex testing to decrease the impediments in reporting cytoplasmic ANA patterns. Hintergrund Antinukleäre Antikörper (ANA) werden als nukleäre, zytoplasmatische oder mitotische Muster klassifiziert. Der internationale Konsens zur ANA-Bestimmung (ICAP) schlägt drei Parameter für die ANA-Berichterstattung vor – die Art des Tests, dessen Ergebnisse und Empfehlungen für Reflextests. Für die Meldung zytoplasmatischer/mitotischer Muster als ANA-negativ oder -positiv wurde jedoch noch kein Konsens erzielt. Wir untersuchten die Auswirkungen der beiden Vorschläge des ICAP für die Meldung von zytoplasmatischen Mustern als ANA-positiv und -negativ auf die Empfehlung für einen Reflextest in einem Land, das über keine nationalen Erstattungsrichtlinien für automatische Reflextests verfügt. Methoden Diese nicht-interventionelle deskriptive Studie umfasste 1241 Patienten mit positiven zytoplasmatischen ANA-Mustern. 442 Patienten wurden als ANA-negativ eingestuft und 799 als ANA-positiv. Zur Ermittlung der Testempfehlungen auf Grundlage der nukleären und zytoplasmatischen Muster wurden die Patienten über einen Zeitraum von zwei Jahren nachbeobachtet. Für die statistische Analyse wurde der t-Test mit einer Signifikanzschwelle von p-Wert<0,05 angewendet. Ergebnisse Ordnungsgemäße Anordnungen von Reflextests wurden häufiger bei zytoplasmatischen Mustern gesehen, die als ANA-positiv angezeigt wurden (27,30%) als bei negativen (5,51%, p-Wert<0,05). Bei ANA-positiven Befunden wurde jedoch häufiger ein Kernmuster-Reflextest angeordnet (12,97%) als bei ANA-negativen Befunden (1,10%, p-Wert<0,05). Bei einer großen Gruppe von Patienten (59,73% ANA-positiv, 93,39% ANA-negativ) wurden keine Reflextests angeordnet. Schlussfolgerung Die Meldung von zytoplasmatischen Mustern als ANA-positiv wurde als aussagekräftiger erachtet. Das Lesen des Ergebnisberichts ohne Berücksichtigung des Musters und der Empfehlungshinweise könnte jedoch zu unangebrachten Reflextests führen. Neben der Erzielung eines Konsenses zur Meldung zytoplasmatischer Muster als ANA-negativ oder -positiv ist es wichtig, Lösungen für die Erstattungsrichtlinien für automatische Reflextests zu prüfen, um die Hindernisse bei der Meldung zytoplasmatischer ANA-Muster zu verringern. Article published online: 19 September 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

9 February 2026 in Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
NKNilgun Kasifoglu
Nilgun Kasifoglu
NUNeval yurttutan uyar
Neval yurttutan uyar
EYEkrem Yasar
Ekrem Yasar
NKNese Kaklikkaya
Nese Kaklikkaya
TTTutku Taskinoglu
Tutku Taskinoglu
BSBurcin Sener
Burcin Sener
Introduction: Accurate and harmonized antinuclear antibody HEp-2 indirect immunofluorescence (IIF) reporting is essential for reliable communication between laboratories and clinicians. In Türkiye, a national online HEp-2 IIF competency assessment program has been operating since 2018, with 3 runs per year and participation of individual users representing clinical laboratories nationwide. The program evaluates the performance of participants and identifies training and reporting needs. Methods: Between 2018 and 2025, 21 runs were conducted; the accuracy of competent-level and expert-level fluorescence pattern identification was analyzed. Twenty-six to 64 participants took part in each run. Since 2021, reflex test recommendations have been incorporated. Results: The competent-level fluorescence patterns most accurately identified were AC-1, AC-3, AC-6/7, AC-8/9/10, AC-11/12, and AC-15/16/17, while AC-0 and AC-2/30 showed less than 80% accuracy in at least 1 run. Among expert-level patterns, accuracy was highest for pattern AC-27 and lowest for pattern AC-29, with low rates for AC-5, AC-6, AC-15, and AC-20. Reflex test recommendations were generally accurate (75.6%-100%). Discussion: The results revealed good performance for many competent-level nuclear and cytoplasmic patterns and satisfactory reflex test recommendations. Persistent challenges were recognized, however, for patterns AC-29, AC-5, AC-20, and AC-0. Competency self-assessment, combined with collective performance evaluation, may provide insight for the harmonization of HEp-2 IIF reporting and improvement of laboratory-clinician collaboration.

24 April 2019
Verified
Book Chapter
Open access
PDF file
NUNeval yurttutan uyar
Neval yurttutan uyar
Prevalence of autoimmune diseases is increasing. Antibodies are responsible for the humoral type of adaptive immune responses, glycoprotein structure and produced by B lymphocytes. Failure of Immunologic self-tolerance due to environmental and genetic factors may predipose the development of autoimmunity. Self-antigens are either tolerogenic or ignored. Central tolerance occurs at immature T and B lymphocytes in the thymus and bone marrow. Peripheral tolerance occurs at mature lymphocytes encounter self-antigens in peripheral tissues. Negative selection, regulatory T cells, anergy, activation-induced cell death, immune suppression, receptor editing are examples of important steps of immune tolerance. B lymphocytes that produce antibodies which bind self-antigen with medium/low affinity escape from anergy and those antibodies are called as natural autoantibodies but the other ones with high affinity are undergo anergy, The natural antibodies have play critical roles as; discrimination foreign from self, auto-multireactivity, regulate the immunomodulation, maintain tissue homeostasis. Natural autoantibodies work as the templates for the production of pathogenic autoantibodies which has high affinity, switch the class and diverse somatically under proper conditions. Pathogenic autoantibodies can protect or cause diseases via neutralization of self-antigens, opsonization, antibody-dependent cellular cytotoxicity, activation of the complement system, pro-inflammatory and anti-inflammatory effect.